Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kousis PC"'
Autor:
Ayline Kübler, Bühring Hj, Leibold Js, Ludger Grosse-Hovest, Kousis Pc, Gundram Jung, Sebastian P. Haen, Maya C. André, Helmut R. Salih, Samuel Koerner, Marina Pal
Publikováno v:
Leukemia. 31(2)
Antibody-dependent cellular cytotoxicity (ADCC) of natural killer (NK) cells largely contributes to the success of monoclonal antibody (mAb) treatment in cancer. As no antibodies are clinically available for immunotherapy of myeloid leukemias (MLs),
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Koerner SP; Department for Internal Medicine II, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tuebingen, Germany.; Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany., André MC; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University, Tuebingen, Germany.; Department of Pediatric Intensive Care, University Children's Hospital, Basel, Switzerland., Leibold JS; Department for Immunology, Eberhard Karls University, Tuebingen, Germany., Kousis PC; Department for Internal Medicine II, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tuebingen, Germany.; Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany., Kübler A; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Pal M; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Haen SP; Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany.; Department for Immunology, Eberhard Karls University, Tuebingen, Germany., Bühring HJ; Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany., Grosse-Hovest L; Department for Immunology, Eberhard Karls University, Tuebingen, Germany., Jung G; Department for Immunology, Eberhard Karls University, Tuebingen, Germany., Salih HR; Department for Internal Medicine II, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tuebingen, Germany.; Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany.
Publikováno v:
Leukemia [Leukemia] 2017 Feb; Vol. 31 (2), pp. 459-469. Date of Electronic Publication: 2016 Jul 20.
Autor:
Raab S; Department of Hematology and Oncology, Eberhard Karls University, D-72076 Tuebingen, Germany; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium and German Cancer Research Center, D-69120 Heidelberg, Germany;, Steinbacher J; Department of Hematology and Oncology, Eberhard Karls University, D-72076 Tuebingen, Germany; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium and German Cancer Research Center, D-69120 Heidelberg, Germany;, Schmiedel BJ; Department of Hematology and Oncology, Eberhard Karls University, D-72076 Tuebingen, Germany; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium and German Cancer Research Center, D-69120 Heidelberg, Germany;, Kousis PC; Department of Hematology and Oncology, Eberhard Karls University, D-72076 Tuebingen, Germany; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium and German Cancer Research Center, D-69120 Heidelberg, Germany;, Steinle A; Institute for Molecular Medicine, Goethe University, D-60590 Frankfurt am Main, Germany; and., Jung G; Department of Immunology, Eberhard Karls University, D-72076 Tuebingen, Germany., Grosse-Hovest L; Department of Immunology, Eberhard Karls University, D-72076 Tuebingen, Germany., Salih HR; Department of Hematology and Oncology, Eberhard Karls University, D-72076 Tuebingen, Germany; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium and German Cancer Research Center, D-69120 Heidelberg, Germany; Helmut.Salih@med.uni-tuebingen.de.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2014 Oct 15; Vol. 193 (8), pp. 4261-72. Date of Electronic Publication: 2014 Sep 12.
Autor:
Mukherjee S; Department of Pathology, University of Michigan, Ann Arbor, MI 48109;, Rasky AJ, Lundy PA, Kittan NA, Kunkel SL, Maillard IP, Kowalski PE, Kousis PC, Guidos CJ, Lukacs NW
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2014 Feb 01; Vol. 192 (3), pp. 996-1003. Date of Electronic Publication: 2013 Dec 23.
Autor:
Xu K; Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, M5G 1L7, Canada., Usary J; Lineberger Comprehensive Cancer Center, Departments of Genetics and Pathology, University of North Carolina, Chapel Hill, NC 27599, USA., Kousis PC; Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, M5G 1L7, Canada., Prat A; Lineberger Comprehensive Cancer Center, Departments of Genetics and Pathology, University of North Carolina, Chapel Hill, NC 27599, USA., Wang DY; The Campbell Family Cancer Research Institute and Surgical Oncology Princess Margaret Hospital, and the Department of General Surgery, University Health Network, Toronto, ON M5S 1A1, Canada., Adams JR; Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A1, Canada., Wang W; Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, M5G 1L7, Canada., Loch AJ; Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, M5G 1L7, Canada., Deng T; Division of Cell and Molecular Biology, Toronto General Research Institute, University Health Network, Toronto, ON M5S 1A1, Canada., Zhao W; Lineberger Comprehensive Cancer Center, Departments of Genetics and Pathology, University of North Carolina, Chapel Hill, NC 27599, USA., Cardiff RD; Center for Comparative Medicine, University of California, Davis, CA 95616, USA., Yoon K; Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA., Gaiano N; Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA., Ling V; Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, M5G 1L7, Canada; Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, M5G 1L7, Canada., Beyene J; Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, M5G 1L7, Canada., Zacksenhaus E; Division of Cell and Molecular Biology, Toronto General Research Institute, University Health Network, Toronto, ON M5S 1A1, Canada., Gridley T; Center for Molecular Medicine, Maine Medical Center Research Institute, 81 Research Drive, Scarborough, ME 04074, USA., Leong WL; The Campbell Family Cancer Research Institute and Surgical Oncology Princess Margaret Hospital, and the Department of General Surgery, University Health Network, Toronto, ON M5S 1A1, Canada., Guidos CJ; Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, M5G 1L7, Canada; Department of Immunology, University of Toronto, Toronto, ON M5S 1A1, Canada., Perou CM; Lineberger Comprehensive Cancer Center, Departments of Genetics and Pathology, University of North Carolina, Chapel Hill, NC 27599, USA., Egan SE; Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, M5G 1L7, Canada; The Campbell Family Cancer Research Institute and Surgical Oncology Princess Margaret Hospital, and the Department of General Surgery, University Health Network, Toronto, ON M5S 1A1, Canada. Electronic address: segan@sickkids.ca.
Publikováno v:
Cancer cell [Cancer Cell] 2012 May 15; Vol. 21 (5), pp. 626-641.
Autor:
Suliman S; Program in Stem Cell and Developmental Biology, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada., Tan J, Xu K, Kousis PC, Kowalski PE, Chang G, Egan SE, Guidos C
Publikováno v:
PloS one [PLoS One] 2011; Vol. 6 (9), pp. e24937. Date of Electronic Publication: 2011 Sep 13.
Autor:
Kousis PC; Department of Cell Stress Biology and the Photodynamic Therapy Center, Roswell Park Cancer Institute, Buffalo, NY 14263, USA., Henderson BW, Maier PG, Gollnick SO
Publikováno v:
Cancer research [Cancer Res] 2007 Nov 01; Vol. 67 (21), pp. 10501-10.